Therapeutic effect of anti-OX40L and anti-TNF-α MAbs in a murine model of chronic colitis

Interaction of OX40 (CD134) on T cells with its ligand (OX40L) on antigen-presenting cells has been implicated in pathogenic T cell activation. This study was performed to explore the involvement o...

[1]  R. Murali,et al.  The TNF receptor superfamily , 2003, Immunologic research.

[2]  D. Podolsky,et al.  Inflammatory bowel disease. , 2002, The New England journal of medicine.

[3]  F. Powrie,et al.  CD134L Expression on Dendritic Cells in the Mesenteric Lymph Nodes Drives Colitis in T Cell-Restored SCID Mice1 , 2001, The Journal of Immunology.

[4]  C. Chambers.  The expanding world of co-stimulation: the two-signal model revisited. , 2001, Trends in immunology.

[5]  J. Gutiérrez-Ramos,et al.  The expanding B7 superfamily: Increasing complexity in costimulatory signals regulating T cell function , 2001, Nature Immunology.

[6]  K. Okumura,et al.  Pathogenic T Cells OX 40 Ligand in Migration , But Not Monoclonal Antibody : A Critical Role for Encephalomyelitis with Anti-OX 40 Ligand Amelioration of Experimental Autoimmune , 2001 .

[7]  R. Flavell,et al.  Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration. , 2000, Gastroenterology.

[8]  D. Granger,et al.  Cytokine and adhesion molecule expression in SCID mice reconstituted with CD4+ T cells. , 2000 .

[9]  S. Kawachi,et al.  Cytokine and Adhesion Molecule Expression in SCID Mice Reconstituted with CD4+ T Cells , 2000, Inflammatory bowel diseases.

[10]  P. Rutgeerts,et al.  Prevention of Experimental Colitis in SCID Mice Reconstituted with CD45RBhigh CD4+ T Cells by Blocking the CD40-CD154 Interactions1 , 2000, The Journal of Immunology.

[11]  T. Kishimoto,et al.  IL-6 Is Required for the Development of Th1 Cell-Mediated Murine Colitis1 , 2000, The Journal of Immunology.

[12]  T. Noda,et al.  Impairment of Antigen-Presenting Cell Function in Mice Lacking Expression of Ox40 Ligand , 2000, The Journal of experimental medicine.

[13]  R. Locksley,et al.  Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). , 1999, Journal of immunology.

[14]  C. Elia,et al.  Expression of lymphocyte-endothelial receptor-ligand pairs, α4β7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease , 1999, Gut.

[15]  M. Bachmann,et al.  OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. , 1999, Immunity.

[16]  G. Freeman,et al.  Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. , 1999, Immunity.

[17]  H. Ogata,et al.  Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa. , 1999, Gastroenterology.

[18]  K. Takeda,et al.  CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. , 1999, Journal of immunology.

[19]  G. Kollias,et al.  Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. , 1999, Immunity.

[20]  S. McDonald,et al.  Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. , 1999, Journal of immunology.

[21]  H. Nakano,et al.  Cells by OX 40 Ligand and CD 70 on Activated B CD 28-Independent Costimulation of T Cells , 1999 .

[22]  M. Croft,et al.  Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. , 1998, Journal of immunology.

[23]  C. Fiocchi.  Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.

[24]  R. Cattaneo,et al.  CD134/OX40 expression by synovial fluid CD4+ T lymphocytes in chronic synovitis. , 1998, British journal of rheumatology.

[25]  M. Croft,et al.  Molecule for Sustaining Primary CD 4 T Cell Ox-40 Ligand : A Potent Costimulatory , 1998 .

[26]  W. B. van den Berg,et al.  Th1/Th2 cytokine balance in arthritis. , 1997, Arthritis and rheumatism.

[27]  Yuetsu Tanaka,et al.  Expression and function of OX40 ligand on human dendritic cells. , 1997, Journal of immunology.

[28]  S. Targan,et al.  A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease , 1997 .

[29]  A. Imura,et al.  Localization of OX40/gp34 in inflammatory skin diseases: a clue to elucidate the interaction between activated T cells and endothelial cells in infiltration , 1997, Archives of Dermatological Research.

[30]  G. Kollias,et al.  Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice , 1997, European journal of immunology.

[31]  A. Weinberg,et al.  Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease. , 1997, Blood.

[32]  G. Milligan,et al.  Tailoring cAMP-signalling responses through isoform multiplicity. , 1997, Trends in biochemical sciences.

[33]  T. Mak,et al.  Costimulation of CD28- T lymphocytes by 4-1BB ligand. , 1997, Journal of immunology.

[34]  L. Nicholson,et al.  Manipulation of the Th1/Th2 balance in autoimmune disease. , 1996, Current opinion in immunology.

[35]  R. Flavell,et al.  A central role of CD40 ligand in the regulation of CD4+ T-cell responses. , 1996, Immunology today.

[36]  A. Barclay,et al.  OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand , 1996, European journal of immunology.

[37]  Claudia Mauri,et al.  Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen‐induced arthritis , 1996, European journal of immunology.

[38]  Yuetsu Tanaka,et al.  The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells , 1996, The Journal of experimental medicine.

[39]  W. Strober,et al.  The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response , 1996, The Journal of experimental medicine.

[40]  E Stuber,et al.  Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion , 1996, The Journal of experimental medicine.

[41]  A. Weinberg,et al.  OX‐40 antibody enhances for autoantigen specific Vβ8.2+ T cells within the spinal cord of lewis rats with autoimmune encephalomyelitis , 1996, Journal of neuroscience research.

[42]  F. Ramsdell,et al.  Fas and FasL in the homeostatic regulation of immune responses. , 1995, Immunology today.

[43]  P. Linsley,et al.  CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. , 1995, Journal of immunology.

[44]  Z. Lee,et al.  Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28. , 1995, Journal of immunology.

[45]  F. Powrie,et al.  T cells in inflammatory bowel disease: protective and pathogenic roles. , 1995, Immunity.

[46]  D. Hommes,et al.  Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). , 1995, Gastroenterology.

[47]  Laurie H Glimcher,et al.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.

[48]  E. Shevach,et al.  Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. , 1994 .

[49]  E. Engleman,et al.  Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor , 1994, The Journal of experimental medicine.

[50]  J. Bluestone,et al.  The B7 and CD28 receptor families. , 1994, Immunology today.

[51]  Terry Farrah,et al.  The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.

[52]  K P Lee,et al.  Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.

[53]  D. Podolsky,et al.  Inflammatory bowel disease (1) , 1991, The New England journal of medicine.

[54]  A. Barclay,et al.  Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes‐‐a molecule related to nerve growth factor receptor. , 1990, The EMBO journal.